Octagon Capital Advisors LP A Tyr Pharma Inc Transaction History
Octagon Capital Advisors LP
- $263 Million
- Q2 2025
A detailed history of Octagon Capital Advisors LP transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Octagon Capital Advisors LP holds 3,820,000 shares of LIFE stock, worth $7.11 Million. This represents 2.7% of its overall portfolio holdings.
Number of Shares
3,820,000
Previous 3,552,000
7.55%
Holding current value
$7.11 Million
Previous $6.61 Million
7.55%
% of portfolio
2.7%
Previous 2.2%
Shares
5 transactions
Others Institutions Holding LIFE
# of Institutions
116Shares Held
49.8MCall Options Held
743KPut Options Held
485K-
Federated Hermes, Inc. Pittsburgh, PA14.7MShares$27.3 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.66MShares$8.66 Million0.0% of portfolio
-
Tikvah Management LLC Charlotte, NC2.46MShares$4.58 Million1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA2.1MShares$3.9 Million0.0% of portfolio
-
Ubs Group Ag1.75MShares$3.25 Million0.0% of portfolio
About aTYR PHARMA INC
- Ticker LIFE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,625,000
- Market Cap $53.2M
- Description
- aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...